Fibromyalgia or widespread pain may increase suicide risk

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-11-16 04:00 GMT   |   Update On 2023-11-16 04:00 GMT

A recent study delved into the contentious issue of mortality risk among patients with fibromyalgia research. Conducted by scrutinizing seven cohort studies and encompassing 152,933 individuals this analysis spanned over the years 2001 to 2020.

Researchers have found in the new study that fibromyalgia or widespread pain was not associated with all-cause mortality. However, it is worth noting that there may be a potential correlation between individuals with fibromyalgia or widespread pain and a higher likelihood of suicide.

Advertisement

The critical findings of this analysis were published in International Journal of Rheumatic Diseases.

This research challenges preconceptions by not finding concrete evidence linking fibromyalgia or widespread pain to all-cause mortality. However, the study underscores a potential correlation between fibromyalgia and a heightened risk of suicide. Acknowledging the limitations of the study due to the participant pool, the study team emphasize the need for further extensive research to unravel the intricate relationship between fibromyalgia and mortality risks.

This study sheds light on a new dimension in fibromyalgia research, emphasizing the importance of understanding the nuanced aspects of this condition and its impact on mental health. The quest for a comprehensive understanding of fibromyalgia and its associated risks continues, offering hope for improved care and support for those affected by this challenging condition.

Reference: Wang, H., Li, X., Wang, X., Chen, M., Wen, C., He, Z., & Huang, L. (2023). Fibromyalgia and risk of all‐cause, specific mortality: A meta‐analysis of observational studies. In International Journal of Rheumatic Diseases. Wiley. https://doi.org/10.1111/1756-185x.14905

Full View
Tags:    
Article Source : International Journal of Rheumatic Diseases

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News